-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Maternal Health: Fertility Preservation in Hematology Care

Program: Special-Interest Sessions
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Workforce, Diversity, Equity, and Inclusion (DEI) , Maternal Health
Sunday, December 10, 2023: 9:30 AM-11:00 AM
Ballroom 20AB (San Diego Convention Center)
Sarah O'Brien, MD, MSc, Nationwide Children's Hospital
O'Brien: AstraZeneca: Consultancy; Bristol Myers Squibb: Research Funding; Pharmacosmos: Honoraria.
Both patients with hematologic conditions and their hematologists face a complex set of challenges when considering options for fertility preservation. With new technologies available and a broader understanding of the need for fertility preservation, there are more opportunities available. This session will explore why there has been such a marked increase in demand for these options, what exactly the options and techniques available are and what both hematologists and their patients need to expect in success rates, complications and demands on their already busy schedules.

Erica Marsh, MD, MSCI, FACOG

University of Michigan, Ann Arbor, MI

Alison W Loren, MD

University of Pennsylvania, Philadelphia, PA

Mindy Christianson, MD, MBA

Cleveland Clinic, Cleveland, OH